financetom
Business
financetom
/
Business
/
Oil Prices Ease as China's Q3 Growth Misses Target
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oil Prices Ease as China's Q3 Growth Misses Target
Oct 18, 2024 6:36 AM

09:05 AM EDT, 10/18/2024 (MT Newswires) -- Oil prices eased early on Friday as China's third-quarter economic growth failed to meet its target, keeping demand from the No.1 importer light.

West Texas Intermediate crude for November delivery was last seen down US$0.23 to US$70.44 per barrel, while December Brent crude, the global benchmark, was down US$0.25 to US$74.20.

China reported its economy grew 4.6% in the third quarter, under the country's 5% target for the second-straight quarter as its economy continues to struggle amid a debt crisis in its real-estate sector and weak consumer spending.

"The second-biggest economy in the world was responsible for 70% of the demand growth last year. This share plummeted to 20% in 2024," PVM Oil Associates noted.

The drop comes even after the Energy Information Administration on Thursday reported that U.S. inventories dropped by 2.2-million barrels last week.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,917,475, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,917,475, According to a Recent SEC Filing
Jun 26, 2024
04:34 PM EDT, 06/26/2024 (MT Newswires) -- Yvonne Greenstreet, Director, Chief Executive Officer, on June 24, 2024, sold 8,301 shares in Alnylam Pharmaceuticals ( ALNY ) for $1,917,475. Following the Form 4 filing with the SEC, Greenstreet has control over a total of 80,941 shares of the company, with 80,534 shares held directly and 407 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1178670/000173527624000068/xslF345X03/edgardoc.xml...
Galaxy Digital Joining Forces with State Street Global Advisors On Digital Asset Investing
Galaxy Digital Joining Forces with State Street Global Advisors On Digital Asset Investing
Jun 26, 2024
04:35 PM EDT, 06/26/2024 (MT Newswires) -- State Street Global Advisors, the asset-management business of State Street (STT), and Galaxy Digital Holdings' ( BRPHF ) Galaxy Asset Management unit, after trade Wednesday announced they are collaborating to bring investors the next generation of digital asset based strategies that will offer exposure to companies involved in the digital asset space, going...
Alnylam Pharmaceuticals Insider Sold Shares Worth $370,747, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $370,747, According to a Recent SEC Filing
Jun 26, 2024
04:35 PM EDT, 06/26/2024 (MT Newswires) -- Jeffrey V. Poulton, Executive Vice President, Chief Financial Officer, on June 24, 2024, sold 1,605 shares in Alnylam Pharmaceuticals ( ALNY ) for $370,747. Following the Form 4 filing with the SEC, Poulton has control over a total of 28,949 shares of the company, with 28,892 shares held directly and 57 controlled indirectly....
Alnylam Pharmaceuticals Insider Sold Shares Worth $485,773, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $485,773, According to a Recent SEC Filing
Jun 26, 2024
04:33 PM EDT, 06/26/2024 (MT Newswires) -- Pushkal Garg, Chief Medical Officer and Executive Vice President of Development and Medical Affairs, on June 24, 2024, sold 2,103 shares in Alnylam Pharmaceuticals ( ALNY ) for $485,773. Following the Form 4 filing with the SEC, Garg has control over a total of 16,290 shares of the company, with 15,609 shares held...
Copyright 2023-2026 - www.financetom.com All Rights Reserved